tiprankstipranks
Zentalis Pharmaceuticals (ZNTL)
NASDAQ:ZNTL
US Market

Zentalis Pharmaceuticals (ZNTL) Income Statement

Compare
303 Followers

Zentalis Pharmaceuticals Income Statement

Last quarter (Q3 2024), Zentalis Pharmaceuticals's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Zentalis Pharmaceuticals's net income was $-40.16M. See Zentalis Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -1.39M$ -1.43M$ -544.00K$ -160.00K$ -111.00K
Operating Expenses
$ 252.55M$ 227.29M$ 216.54M$ 118.79M$ 46.84M
Depreciation and Amortization
$ 1.39M$ 1.43M$ 544.00K$ 160.00K$ 111.00K
EBITDA
$ -275.50M$ -219.87M$ -164.01M$ -117.94M$ -46.73M
Operating Income
$ -248.99M$ -227.29M$ -216.54M$ -118.79M$ -46.84M
Other Income/Expenses
$ -27.90M$ 5.99M$ 51.98M$ 683.00K$ 482.00K
Pretax Income
$ -276.89M$ -221.30M$ -164.56M$ -118.10M$ -46.36M
Net Income
$ -292.19M$ -220.83M$ -164.26M$ -118.55M$ -46.38M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -4.47$ -4.18$ -3.85$ -2.89$ -1.29
Diluted EPS
$ -4.47$ -4.18$ -3.85$ -2.89$ -1.29
Weighted Average Shares Outstanding
65.41M 52.86M 42.69M 41.04M 35.88M
Weighted Average Shares Outstanding (Diluted)
65.41M 52.86M 42.69M 41.04M 35.88M
Currency in USD

Zentalis Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis